Edward Routledge
Base: UK


Ed has considerable experience in both industry and academia. Before joining VorteQ, he was head of the Mammalian Cell Culture R&D group at Angel Biotechnology, a UK-based contract research and manufacturing company. There he was responsible for pre-GMP management of client projects and for the design and running of in-house research projects.

Prior to that, he spent over fifteen years conducting academic research at prestigious institutions including: Cambridge University (UK), the University of Wurzburg (Germany) and Newcastle University (UK). His research focused on monoclonal antibody technologies, therapeutic immunology, genetically engineered antibodies and molecular virology.

Ed received his Ph.D. in Virology from University of Newcastle upon Tyne (now Newcastle University).

Edward Routledge